Chloroquine and hydroxychloroquine for COVID-19 treatment
Coronavirus disease 2019 (COVID-19) is an emerging disease caused bysevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has been causing many people around the world affected. There is no approved treatment for COVID-19. Meanwhile, vaccine development still needs a long time before it...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Gadjah Mada
2020-05-01
|
Series: | Journal of the Medical Sciences |
Subjects: | |
Online Access: | https://jurnal.ugm.ac.id/bik/article/view/55841 |
id |
doaj-63feeb9963974dd9a9ebdbc64980dbcf |
---|---|
record_format |
Article |
spelling |
doaj-63feeb9963974dd9a9ebdbc64980dbcf2020-11-25T03:58:18ZengUniversitas Gadjah MadaJournal of the Medical Sciences0126-13122356-39312020-05-0152310.19106/JMedSciSI00520320200226908Chloroquine and hydroxychloroquine for COVID-19 treatmentDwi Aris Agung Nugrahaningsih0Eko Purnomo1Department of Pharmacology and Therapy, Faculty of Medicine, Public Health, and Nursing Universitas Gadjah MadaDivision of Pediatric Surgery, Department of Pediatric Surgery, Faculty of Medicine, Public Health and Nursing/ Academic Hospital, Universitas Gadjah Mada, IndonesiaCoronavirus disease 2019 (COVID-19) is an emerging disease caused bysevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has been causing many people around the world affected. There is no approved treatment for COVID-19. Meanwhile, vaccine development still needs a long time before it becomes available to protect people from contracting COVID-19. Repurposing the available drugs is one of the fastest ways to get COVID-19 treatment. Studies have been conducted to discover for COVID-19 treatment that results in the finding of potential medication for COVID-19. Chloroquine and hydroxychloroquine are some of the available medication that shows potential for COVID-19 treatment. Preclinical study showed that the both drugs are active against SARS-CoV-2 in vitro. A pilot clinical study also showed their efficacy in COVID-19 treatment. Many clinical trials are now being conducted to prove their safety and efficacy for the prevention and treatment of COVID-19. However, until now there are not enough data to support the use of these drugs in COVID-19 management. Under the pressure to treat COVID-19 patients with chloroquine or hydroxychloroquine, clinicians shouldnot use these drugs for COVID-19 without considering the available information regarding theiruse for COVID-19. This review summarized the evidence regarding the potential of chloroquine and hydroxychloroquine in COVID-19 management.https://jurnal.ugm.ac.id/bik/article/view/55841chloroquinehydroxychloroquinecovid-19 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dwi Aris Agung Nugrahaningsih Eko Purnomo |
spellingShingle |
Dwi Aris Agung Nugrahaningsih Eko Purnomo Chloroquine and hydroxychloroquine for COVID-19 treatment Journal of the Medical Sciences chloroquine hydroxychloroquine covid-19 |
author_facet |
Dwi Aris Agung Nugrahaningsih Eko Purnomo |
author_sort |
Dwi Aris Agung Nugrahaningsih |
title |
Chloroquine and hydroxychloroquine for COVID-19 treatment |
title_short |
Chloroquine and hydroxychloroquine for COVID-19 treatment |
title_full |
Chloroquine and hydroxychloroquine for COVID-19 treatment |
title_fullStr |
Chloroquine and hydroxychloroquine for COVID-19 treatment |
title_full_unstemmed |
Chloroquine and hydroxychloroquine for COVID-19 treatment |
title_sort |
chloroquine and hydroxychloroquine for covid-19 treatment |
publisher |
Universitas Gadjah Mada |
series |
Journal of the Medical Sciences |
issn |
0126-1312 2356-3931 |
publishDate |
2020-05-01 |
description |
Coronavirus disease 2019 (COVID-19) is an emerging disease caused bysevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has been causing many people around the world affected. There is no approved treatment for COVID-19. Meanwhile, vaccine development still needs a long time before it becomes available to protect people from contracting COVID-19. Repurposing the available drugs is one of the fastest ways to get COVID-19 treatment. Studies have been conducted to discover for COVID-19 treatment that results in the finding of potential medication for COVID-19. Chloroquine and hydroxychloroquine are some of the available medication that shows potential for COVID-19 treatment. Preclinical study showed that the both drugs are active against SARS-CoV-2 in vitro. A pilot clinical study also showed their efficacy in COVID-19 treatment. Many clinical trials are now being conducted to prove their safety and efficacy for the prevention and treatment of COVID-19. However, until now there are not enough data to support the use of these drugs in COVID-19 management. Under the pressure to treat COVID-19 patients with chloroquine or hydroxychloroquine, clinicians shouldnot use these drugs for COVID-19 without considering the available information regarding theiruse for COVID-19. This review summarized the evidence regarding the potential of chloroquine and hydroxychloroquine in COVID-19 management. |
topic |
chloroquine hydroxychloroquine covid-19 |
url |
https://jurnal.ugm.ac.id/bik/article/view/55841 |
work_keys_str_mv |
AT dwiarisagungnugrahaningsih chloroquineandhydroxychloroquineforcovid19treatment AT ekopurnomo chloroquineandhydroxychloroquineforcovid19treatment |
_version_ |
1724458125939965952 |